| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.025 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |